Inflammatix, Inc.

863 Mitten Road Suite 104
Burlingame, CA 94010
United States

Tel: (650) 443-3030


Show jobs for this employer

About Inflammatix, Inc.

Inflammatix, Inc. is a venture-backed diagnostics company bringing the power of precision medicine to the point- of-care. We are building novel diagnostic, prognostic, and predictive tests that combine rapid detection of human immune gene expression (mRNA) panels with advanced machine learning. These tests will be performed on our rapid point-of-care instrument currently under development. Our first tests, planned to be commercialized in 2021, will enable physicians to better diagnose acute infections and sepsis (including COVID-19).


Dr. Tim Sweeney, Inflammatix Co-Founder and CEO TEDx Palo Alto: 'The power of reading the immune system to better diagnose disease'

11 articles with Inflammatix, Inc.